Rare diseases
Investigational molecules
Locations
706 conditions with trials, the busiest first
3 926 trials across Europe, recruiting first
A study of RPTR-1-201 and pembrolizumab in patients with advanced solid tumors
FranceA study of YL201 and atezolizumab for patients with advanced solid tumors
BelgiumStudy to evaluate the efficacy and safety of deucrictibant for the prevention and treatment of angioedema attacks in adults with acquired angioedema
AustriaA study of ulixertinib, tovorafenib, and vinblastine sulfate for children with progressive, relapsed, or refractory low-grade glioma
AustriaA study of emavusertib and zanubrutinib in patients with chronic lymphocytic leukemia and other B-cell cancers.
ItalyA study of irinotecan and a drug combination for patients with gastric cancer or gastroesophageal junction cancer undergoing surgery.
The NetherlandsStudy of elacestrant and ribociclib compared to standard treatment for patients with high-risk ER+/HER2- early breast cancer
AustriaStudy of the use of tasadenoturev for children and young adults with recurrent or resistant high-grade brain tumors
The NetherlandsA study of pumitamig and a drug combination versus nivolumab and a drug combination for patients with untreated advanced or metastatic stomach or esophageal cancer
FranceA study of pumitamig and a drug combination versus bevacizumab and a drug combination for patients with untreated, unresectable, or metastatic colorectal cancer
AustriaA study to evaluate the effectiveness of epcoritamab in patients with Waldenström's macroglobulinemia that has returned or has not responded to previous treatments.
BelgiumA study to compare glofitamab against a drug combination for patients with relapsed or refractory mantle cell lymphoma
FranceThe therapies tested most often in Neoplasms benign, malignant and unspecified (incl cysts and polyps) trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
